We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$1.67B
1-Year Est. Return
1.43%
This Fund
S&P 500
This Quarter
Est. Return
+1.91%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
–
AUM
$1.67B
AUM Growth
-$505M
(-23%)
Cap. Flow
-$520M
Cap. Flow
% of AUM
-31.03%
Top 10 Holdings %
Top 10 Hldgs %
29.21%
Holding
171
New
21
Increased
23
Reduced
68
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$47.1M |
| 2 |
Becton Dickinson
BDX
|
+$40.9M |
| 3 |
Universal Health Services
UHS
|
+$39.4M |
| 4 |
Intuit
INTU
|
+$37.1M |
| 5 |
SPS Commerce
SPSC
|
+$33.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chord Energy
CHRD
|
+$73.2M |
| 2 |
Teleflex
TFX
|
+$52.2M |
| 3 |
Akamai
AKAM
|
+$46.6M |
| 4 |
RingCentral
RNG
|
+$30.2M |
| 5 |
Haemonetics
HAE
|
+$28.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Healthcare | 19.57% |
| 3 | Industrials | 14.44% |
| 4 | Consumer Discretionary | 10.33% |
| 5 | Communication Services | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Quanterix
QTRX
$125M
| – | – |
-1,932,386
| Closed | -$6.8M |
|
152
LiveRamp
RAMP
$2.29B
| – | – |
-1,011,156
| Closed | -$26.8M |
|
153
CALL
Rivian
RIVN
$23.3B
| – | – |
-890,000
| Closed | -$13.4M |
|
|
RMAX
154
DELISTED
RE/MAX Holdings
RMAX
| – | – |
-195,990
| Closed | -$1.13M |
|
|
155
RingCentral
RNG
$5.79B
| – | – |
-812,308
| Closed | -$30.2M |
|
156
Regal Rexnord
RRX
$10.5B
| – | – |
-97,105
| Closed | -$18.2M |
|
157
Snap
SNAP
$9.18B
| – | – |
-5,260,794
| Closed | -$24.2M |
|
|
SNBR
158
DELISTED
Sleep Number
SNBR
| – | – |
-449,934
| Closed | -$808K |
|
159
Stratasys
SSYS
$678M
| – | – |
-2,037,384
| Closed | -$15.9M |
|
|
160
Teleflex
TFX
$5.92B
| – | – |
-436,125
| Closed | -$52.2M |
|
161
Tyler Technologies
TYL
$15.5B
| – | – |
-7,988
| Closed | -$2.73M |
|
|
UDMY
162
DELISTED
Udemy
UDMY
| – | – |
-1,386,098
| Closed | -$6.4M |
|
163
Visteon
VC
$2.72B
| – | – |
-31,278
| Closed | -$2.85M |
|
164
Vornado Realty Trust
VNO
$7.13B
| – | – |
-91,102
| Closed | -$2.37M |
|
165
Vestis
VSTS
$1.65B
| – | – |
-2,012,989
| Closed | -$15.8M |
|
166
WisdomTree
WT
$3.7B
| – | – |
-581,543
| Closed | -$8.47M |
|
167
Ziff Davis
ZD
$1.91B
| – | – |
-260,392
| Closed | -$10.9M |
|
168
United Parks & Resorts
PRKS
$1.93B
| – | – |
-353,782
| Closed | -$11.6M |
|
169
Solventum
SOLV
$15.5B
| – | – |
-401,156
| Closed | -$26.2M |
|
|
KLC
170
KinderCare Learning Companies
KLC
$308M
| – | – |
-583,486
| Closed | -$1.28M |
|
|
WLTH
171
Wealthfront Corp
WLTH
$1.38B
| – | – |
-643,328
| Closed | -$5.95M |
|
Similar funds
HCA
IAIM
ACM
CC
CUAMC
SH
ZBNA
DG
Invenomic Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Invenomic Capital Management held 171 positions worth $1.67B, down 23% from $2.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invenomic Capital Management withdrew a net $520M in Q2 2026, closing 55 positions and reducing 68 holdings. Its most notable exit was Chord Energy, an estimated $73.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Invenomic Capital Management opened a new position in Charter Communications worth $40.2M.
- Invenomic Capital Management's largest Q2 2026 buy was Charter Communications: 282,416 shares worth $40.2M.
- Invenomic Capital Management added most to Universal Health Services in Q2 2026, an estimated $39.4M increase.
- Invenomic Capital Management's biggest Q2 2026 reduction was Haemonetics, cutting an estimated $28.8M.
- Invenomic Capital Management fully exited Chord Energy in Q2 2026, selling an estimated $73.2M.
- Invenomic Capital Management's ten largest holdings make up 29% of its $1.67B portfolio in Q2 2026.
- Invenomic Capital Management opened 21 new positions and closed 55 in Q2 2026.
- Invenomic Capital Management's portfolio value fell 23% quarter-over-quarter to $1.67B.
Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.